Itraconazole
-
HalcyGen to begin Marketing Authorization Application in Europe
HalcyGen Pharmaceuticals has announced that preliminary results from its UK-based Pharmacokinetic (PK) study comparing a half-dose of anti-fungal drug Suba-Itraconazole with Sporanox, has shown clinical bioequivalence within EU guidelines. Follow…
Itraconazole | 11 March 2010
